OraSure Technologies, Inc.
(NASDAQ : OSUR)

( )
OSUR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
1.12%85.090.6%$483.04m
ISRGIntuitive Surgical, Inc.
1.91%500.422.4%$427.40m
TMOThermo Fisher Scientific Inc.
1.77%263.671.0%$423.24m
ABTAbbott Laboratories
2.13%76.100.8%$406.97m
BDXBecton, Dickinson and Company
1.31%227.991.1%$340.92m
ALGNAlign Technology, Inc.
1.88%296.086.3%$305.74m
BSXBoston Scientific Corporation
2.72%35.881.1%$297.08m
SYKStryker Corporation
2.60%186.901.3%$254.28m
BAXBaxter International Inc.
1.44%76.331.7%$228.48m
ABMDABIOMED, Inc.
0.48%262.183.3%$223.46m
EWEdwards Lifesciences Corporation
1.51%180.961.2%$211.43m
DXCMDexCom, Inc.
1.22%118.038.5%$161.88m
ZBHZimmer Biomet Holdings, Inc.
1.27%122.741.7%$139.47m
WATWaters Corporation
-12.34%211.303.5%$129.03m
TNDMTandem Diabetes Care, Inc.
3.21%58.584.1%$105.80m

Company Profile

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The DNAG segment manufactures and sells specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.